Form 4 · Filed May 8, 2026, 08:44 PM UTC
ELOX/Eloxx Pharmaceuticals, Inc.
Walts Alan Edmund — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jan 24, 2026 | M | other | 1,875 | — | — | 15,567 |
| Jan 24, 2026 | M | other | 1,875 | — | — | 1,875 |
| Sep 19, 2025 | A | other | 395,680 | — | — | 395,680 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-214815